Losartan improves intestinal mucositis induced by 5-fluorouracil in mice
Abstract Intestinal mucositis (IM) is a common side effect of 5-fluorouracil (5-FU)-based chemotherapy, which negatively impacts therapeutic outcomes and delays subsequent cycles of chemotherapy resulting in dose reductions and treatment discontinuation. In search of new pharmacological alternatives...
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
Nature Portfolio
2021-12-01
|
| シリーズ: | Scientific Reports |
| オンライン･アクセス: | https://doi.org/10.1038/s41598-021-01969-x |